Bioteque Corp
Bioteque Corp is a medical equipment and supplies company that generates revenue through the distribution and sale of healthcare products and services.
Business. Bioteque Corp (4107.TWO) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in Taiwan, the company is primarily listed on the Taiwan Premium Exchange (TPEx).
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Bioteque Corp (4107.TWO) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in Taiwan, the company is primarily listed on the Taiwan Premium Exchange (TPEx).
Bioteque Corp maintains a strong capital structure with a debt-to-equity ratio of 0.17, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 4.27, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's net cash position is negative after subtracting total debt, which could signal potential liquidity constraints.
In terms of profitability, Bioteque Corp demonstrates a return on equity (ROE) of 14.95% and a return on assets (ROA) of 11.57%, both of which are strong indicators of efficient capital utilization and asset management. The company's operating margin, calculated as operating income divided by revenue, is 31.4%, which is a key metric for assessing operational efficiency in the medical equipment and supplies industry.
Geographically and segment-wise, the company's revenue concentration is not explicitly detailed in the available data. However, the company's exposure to the healthcare services and equipment sector is significant, with no clear indication of diversification across multiple geographic regions or product lines.
The company's growth trajectory is supported by a positive free cash flow of 302.8 million TWD and a capital expenditure of -57.2 million TWD, indicating that it is generating more cash than it is investing in new capital assets. The outlook for the current fiscal year suggests continued growth, although specific numeric deltas for the next fiscal year are not provided in the available data.
Risk factors for Bioteque Corp include a medium liquidity risk and a low dilution risk. The company's net cash position being negative after subtracting total debt is a notable risk factor that could affect its ability to meet short-term obligations. There is no indication of dilution potential in the basic shares outstanding, as the number of basic and diluted shares is the same.
Recent events and filings have not been detailed in the available data, so there is no specific information on recent corporate actions or regulatory changes that could impact the company's operations or financial performance.
- Bioteque Corp has a strong ROE of 14.95% and ROA of 11.57%, indicating efficient capital and asset utilization.
- The company's liquidity position is medium, with a current ratio of 4.27, but its net cash position is negative after subtracting total debt.
- The company's debt-to-equity ratio of 0.17 suggests a conservative capital structure with low reliance on debt.
- Bioteque Corp generates a positive free cash flow of 302.8 million TWD, supporting its growth and operational flexibility.
- The company's risk assessment indicates a low dilution risk and a medium liquidity risk.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Bioteque Corp Market data — financials · 2026-05-26